These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7143840)

  • 1. [Clinical effect of nifedipine in patients with achalasia].
    Hongo M
    Nihon Heikatsukin Gakkai Zasshi; 1982 Mar; 18(1):39-43. PubMed ID: 7143840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and manometric effects of nifedipine in patients with esophageal achalasia.
    Bortolotti M; Labò G
    Gastroenterology; 1981 Jan; 80(1):39-44. PubMed ID: 7450409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of nifedipine therapy in achalasia: results of a randomized, double-blind, placebo-controlled study.
    Traube M; Dubovik S; Lange RC; McCallum RW
    Am J Gastroenterol; 1989 Oct; 84(10):1259-62. PubMed ID: 2679048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isosorbide dinitrate or nifedipine: which is preferable in the medical therapy of achalasia?
    Bortolotti M; Coccia G; Brunelli F; Sarti P; Mazza M; Bagnato F; Barbara L
    Ital J Gastroenterol; 1994; 26(8):379-82. PubMed ID: 7703511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Return of esophageal peristalsis after nifedipine therapy in patients with idiopathic esophageal achalasia.
    Coccia G; Bortolotti M; Michetti P; Dodero M
    Am J Gastroenterol; 1992 Dec; 87(12):1705-8. PubMed ID: 1449129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isosorbide dinitrate and nifedipine treatment of achalasia: a clinical, manometric and radionuclide evaluation.
    Gelfond M; Rozen P; Gilat T
    Gastroenterology; 1982 Nov; 83(5):963-9. PubMed ID: 6288509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Electromanometric evaluation of the effects of nifedipine in achalasic patients].
    Román García FJ; Bortolotti M; Montes Santiago J; Román García F; González Quintela A
    Rev Esp Enferm Apar Dig; 1987 Jun; 71(6):477-80. PubMed ID: 3616090
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of verapamil on the lower esophageal sphincter pressure in normal subjects and in achalasia.
    Becker BS; Burakoff R
    Am J Gastroenterol; 1983 Dec; 78(12):773-5. PubMed ID: 6650465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nifedipine in achalasia and in patients with high-amplitude peristaltic esophageal contractions.
    Traube M; Hongo M; Magyar L; McCallum RW
    JAMA; 1984 Oct; 252(13):1733-6. PubMed ID: 6471300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective clinical and manometric study comparing pneumatic dilatation and sublingual nifedipine in the treatment of oesophageal achalasia.
    Coccia G; Bortolotti M; Michetti P; Dodero M
    Gut; 1991 Jun; 32(6):604-6. PubMed ID: 2060867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nifedipine on the lower esophageal sphincter pressure in chagasic patients.
    Dantas RO; Godoy RA; Oliveira RB; Villanova MG; Meneghelli UG; Troncon LE
    Braz J Med Biol Res; 1986; 19(2):205-9. PubMed ID: 3103795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical therapy of achalasia: A benefit reserved for few.
    Bortolotti M
    Digestion; 1999; 60(1):11-6. PubMed ID: 9892793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lower esophageal sphincter pressure in patients with achalasia. Is high blood pressure frequent in these patients?].
    Malé Velásquez R; Alvarez C; Ayuso C; Zavala MG; Langle H
    Rev Gastroenterol Mex; 2003; 68(4):258-60. PubMed ID: 15125326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of calcium-antagonists on lower esophageal sphincter pressure. The possibility of application of nifedipine to achalasia].
    Hongo M
    Nihon Shokakibyo Gakkai Zasshi; 1982 Oct; 79(10):1883-91. PubMed ID: 7154348
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of nifedipine on canine LESP (author's transl)].
    Hongo M
    Nihon Heikatsukin Gakkai Zasshi; 1981 Jun; 17(2):47-51. PubMed ID: 7328957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin.
    Neubrand M; Scheurlen C; Schepke M; Sauerbruch T
    Endoscopy; 2002 Jul; 34(7):519-23. PubMed ID: 12170400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of achalasia using balloon dilatation].
    Baumann R; de Peyer R; Dederding JP; Bosson R; Loizeau E
    Schweiz Med Wochenschr; 1990 Sep; 120(36):1304-7. PubMed ID: 2218451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical treatment of esophageal achalasia. Double-blind crossover study with oral nifedipine, verapamil, and placebo.
    Triadafilopoulos G; Aaronson M; Sackel S; Burakoff R
    Dig Dis Sci; 1991 Mar; 36(3):260-7. PubMed ID: 1995258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Esophageal achalasia with apparently normal relaxation of the lower sphincter: clinical significance and therapeutic response to pneumatic dilatation].
    Garrigues Gil V; Ponce García J; Pertejo Pastor V; Gálvez Castillo C; Valverde de la Osa J; Berenguer Lapuerta J
    Rev Esp Enferm Dig; 1996 Aug; 88(8):529-32. PubMed ID: 8962756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of polypeptide hormones on the lower esophageal sphincter in achalasia].
    Siewert R; Früh E; Waldeck F; Schmidt H
    Z Gastroenterol; 1974 Mar; 12(2):117-20. PubMed ID: 4825089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.